Completed OBSERVATIONAL NCT01715623

Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. (PRIERR)

Sponsor: Direction Générale de la Santé, France

Conditions Children With HSP Healthy Volunteers Lymphoma Subject With Allergy

Updated 11 times since 2017 Last updated: Jan 18, 2019 Started: Oct 31, 2012 Primary completion: Apr 30, 2013 Completion: Dec 16, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Children With HSP and Healthy Volunteers, this trial is completed. The trial is conducted by Direction Générale de la Santé, France and has accumulated 11 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Feb 2019 — Nov 2020 [monthly]

Completed
Jun 2018 — Feb 2019 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Direction Générale de la Santé, France
Institut National de la Santé Et de la Recherche Médicale, France
University Hospital, Limoges

Data source: University Hospital, Limoges

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Limoges, France